Givlaari Interactions
There are 233 drugs known to interact with Givlaari (givosiran), along with 1 disease interaction, and 1 alcohol/food interaction. Of the total drug interactions, 45 are major, 186 are moderate, and 2 are minor.
- View all 233 medications that may interact with Givlaari
- View Givlaari alcohol/food interactions (1)
- View Givlaari disease interactions (1)
Most frequently checked interactions
View interaction reports for Givlaari (givosiran) and the medicines listed below.
- Adriamycin (doxorubicin)
- Advate (antihemophilic factor)
- Afinitor Disperz (everolimus)
- Blenoxane (bleomycin)
- Blocadren (timolol)
- Dibenzyline (phenoxybenzamine)
- enalapril
- Epidiolex (cannabidiol)
- Evrysdi (risdiplam)
- fosinopril
- Implanon (etonogestrel)
- Ingrezza (valbenazine)
- InnoPran XL (propranolol)
- Invirase (saquinavir)
- Jynarque (tolvaptan)
- Kalydeco (ivacaftor)
- methylphenidate
- Meticorten (prednisone)
- midazolam
- Mustargen (mechlorethamine)
- Norvir (ritonavir)
- Nydrazid (isoniazid)
- Oncovin (vincristine)
- Panhematin (hemin)
- prednisone
- Prozac (fluoxetine)
- Purixan (mercaptopurine)
- Recombinate (antihemophilic factor)
- Rituxan Hycela (hyaluronidase / rituximab)
- Symdeko (ivacaftor / tezacaftor)
Givlaari alcohol/food interactions
There is 1 alcohol/food interaction with Givlaari (givosiran).
Givlaari disease interactions
There is 1 disease interaction with Givlaari (givosiran) which include:
Report options
QR code containing a link to this page
More about Givlaari (givosiran)
- Givlaari consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous metabolic agents
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
